Biol Sex Differ:不同的胖男胖女面临不同的心血管代谢风险

2018-08-10 BMC中国 BMC期刊

最近发表于Biology of Sex Differences的文章解释了男女身体成分的差异。利用现代解剖学和功能成像技术,作者阐述了脂肪分布的微妙差异,并将其与男女中不同的代谢风险联系起来。

最近发表于Biology of Sex Differences的文章解释了男女身体成分的差异。利用现代解剖学和功能成像技术,作者阐述了脂肪分布的微妙差异,并将其与男女中不同的代谢风险联系起来。

毫无疑问,男性和女性的身体成分不同,男性的脂肪通常积累于腹部,形成典型的苹果型身材,而女性身体呈梨形,下肢脂肪较多。但是这些差异能否会以不同的方式影响男性和女性的健康?

尽管男性和女性都易患肥胖症,但即便其他因素如总脂肪数或体重指数(BMI)相似,肥胖在不同性别中对健康的影响往往是不同的。

这一观察结果使Biology of Sex Differences最新文章的作者认为,例如BMI和总脂肪量等经典指标其实不够灵敏,无法确保准确地了解男性和女性的代谢风险。

马萨诸塞州综合医院和哈佛医学院的Schorr等使用解剖学和功能成像技术相结合,对一组年龄和体重指数相似的超重/肥胖男性和女性的身体成分和异位脂肪沉积进行了深入分析。他们的研究结果支持了性别差异对血管代谢风险的影响大于多余总脂肪量的假设。

苹果和梨型身体形状的一般差异已得到证实,与男性相比,女性下肢的脂肪更多,男性则有更多的内脏脂肪组织(VAT),同时女性总脂肪量也高于男性。然而,在相近的年龄和体重指数下,男性表型与更有害的血管代谢风险特征有关。梨型体型的脂肪堆积于下肢,相比之下则成为一种保护性因素。

尽管在体重范围内男性患心血管代谢疾病的风险高于女性,但随着体重指数的增加,女性心血管代谢风险性别特异性的增加却大于男性。

使用双能X射线吸收测定法、计算机断层扫描和磁共振光谱法评估不同的脂肪区室,包括异位脂肪、瘦肉和肌肉质量,有助于了解其背后的原因。

尽管女性的内脏脂肪组织总体上较少,但与男性相比,女性内脏脂肪组织的累积会导致更大的心血管代谢风险。男性的肝内和肌细胞内脂质含量也高于女性,而肌细胞内脂质是男性而非女性的特殊危害因素。四肢肌肉的存在对两性都有保护作用,这表明即便脂肪量没有改变,肌肉量的增加也可以抵消异位脂肪累积的影响。

总之,我们了解到身体成分如何以性别特异性的方式影响心血管代谢风险:男性总体上更容易患病,但内脏脂肪组织是女性的主要危险因素,肌细胞内脂质是男性危害最大的因素。

这些差异背后的机制仍有待产阐明,但性类固醇和性别特异性遗传决定因素可能是调节身体成分和其与代谢风险之间关系的代表性关键因素。

可以肯定的是,新方法和技术的建立所带来的可能性是充分了解性别特异脂肪分布与代谢风险的基础。

那么目前还需要进行哪些工作?作者强调了确认性别差异与心血管代谢风险之间因果关系的重要性,而我们期待长期的纵向研究,以此评估异位脂肪沉积能否导致男性和女性之间更高的心血管代谢发病率。

原始出处:
Melanie Schorr,  et al. Sex differences in body composition and association with cardiometabolic risk. Biology of Sex Differences. Jun2 2018.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1918235, encodeId=f6a31918235fa, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Mon Oct 15 10:21:00 CST 2018, time=2018-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1767499, encodeId=9cbd1e67499b5, content=<a href='/topic/show?id=64f5343e2f' target=_blank style='color:#2F92EE;'>#Biol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3437, encryptionId=64f5343e2f, topicName=Biol)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=446937890434, createdName=12498ebem31暂无昵称, createdTime=Sun Nov 25 18:21:00 CST 2018, time=2018-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1934423, encodeId=416a193442350, content=<a href='/topic/show?id=333851e5032' target=_blank style='color:#2F92EE;'>#心血管代谢#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51750, encryptionId=333851e5032, topicName=心血管代谢)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2bcd469, createdName=fengting3, createdTime=Wed Nov 28 23:21:00 CST 2018, time=2018-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1784213, encodeId=93a21e84213da, content=<a href='/topic/show?id=f01159527d' target=_blank style='color:#2F92EE;'>#Differ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5952, encryptionId=f01159527d, topicName=Differ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d784426, createdName=isabellayj, createdTime=Sat Jan 26 04:21:00 CST 2019, time=2019-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=337735, encodeId=65ce33e7358b, content=阅, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/fhZdOu27e88Voqh19n8eF8cLplo8L4nicKtH0WnE3KFELXns5XDu8rsiceK2HHDZc2SEStia5VV3Pia2QLMVqlWbHw/0, createdBy=6e012139475, createdName=神功盖世, createdTime=Fri Aug 10 18:13:10 CST 2018, time=2018-08-10, status=1, ipAttribution=)]
    2018-10-15 sunylz
  2. [GetPortalCommentsPageByObjectIdResponse(id=1918235, encodeId=f6a31918235fa, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Mon Oct 15 10:21:00 CST 2018, time=2018-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1767499, encodeId=9cbd1e67499b5, content=<a href='/topic/show?id=64f5343e2f' target=_blank style='color:#2F92EE;'>#Biol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3437, encryptionId=64f5343e2f, topicName=Biol)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=446937890434, createdName=12498ebem31暂无昵称, createdTime=Sun Nov 25 18:21:00 CST 2018, time=2018-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1934423, encodeId=416a193442350, content=<a href='/topic/show?id=333851e5032' target=_blank style='color:#2F92EE;'>#心血管代谢#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51750, encryptionId=333851e5032, topicName=心血管代谢)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2bcd469, createdName=fengting3, createdTime=Wed Nov 28 23:21:00 CST 2018, time=2018-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1784213, encodeId=93a21e84213da, content=<a href='/topic/show?id=f01159527d' target=_blank style='color:#2F92EE;'>#Differ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5952, encryptionId=f01159527d, topicName=Differ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d784426, createdName=isabellayj, createdTime=Sat Jan 26 04:21:00 CST 2019, time=2019-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=337735, encodeId=65ce33e7358b, content=阅, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/fhZdOu27e88Voqh19n8eF8cLplo8L4nicKtH0WnE3KFELXns5XDu8rsiceK2HHDZc2SEStia5VV3Pia2QLMVqlWbHw/0, createdBy=6e012139475, createdName=神功盖世, createdTime=Fri Aug 10 18:13:10 CST 2018, time=2018-08-10, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1918235, encodeId=f6a31918235fa, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Mon Oct 15 10:21:00 CST 2018, time=2018-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1767499, encodeId=9cbd1e67499b5, content=<a href='/topic/show?id=64f5343e2f' target=_blank style='color:#2F92EE;'>#Biol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3437, encryptionId=64f5343e2f, topicName=Biol)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=446937890434, createdName=12498ebem31暂无昵称, createdTime=Sun Nov 25 18:21:00 CST 2018, time=2018-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1934423, encodeId=416a193442350, content=<a href='/topic/show?id=333851e5032' target=_blank style='color:#2F92EE;'>#心血管代谢#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51750, encryptionId=333851e5032, topicName=心血管代谢)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2bcd469, createdName=fengting3, createdTime=Wed Nov 28 23:21:00 CST 2018, time=2018-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1784213, encodeId=93a21e84213da, content=<a href='/topic/show?id=f01159527d' target=_blank style='color:#2F92EE;'>#Differ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5952, encryptionId=f01159527d, topicName=Differ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d784426, createdName=isabellayj, createdTime=Sat Jan 26 04:21:00 CST 2019, time=2019-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=337735, encodeId=65ce33e7358b, content=阅, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/fhZdOu27e88Voqh19n8eF8cLplo8L4nicKtH0WnE3KFELXns5XDu8rsiceK2HHDZc2SEStia5VV3Pia2QLMVqlWbHw/0, createdBy=6e012139475, createdName=神功盖世, createdTime=Fri Aug 10 18:13:10 CST 2018, time=2018-08-10, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1918235, encodeId=f6a31918235fa, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Mon Oct 15 10:21:00 CST 2018, time=2018-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1767499, encodeId=9cbd1e67499b5, content=<a href='/topic/show?id=64f5343e2f' target=_blank style='color:#2F92EE;'>#Biol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3437, encryptionId=64f5343e2f, topicName=Biol)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=446937890434, createdName=12498ebem31暂无昵称, createdTime=Sun Nov 25 18:21:00 CST 2018, time=2018-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1934423, encodeId=416a193442350, content=<a href='/topic/show?id=333851e5032' target=_blank style='color:#2F92EE;'>#心血管代谢#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51750, encryptionId=333851e5032, topicName=心血管代谢)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2bcd469, createdName=fengting3, createdTime=Wed Nov 28 23:21:00 CST 2018, time=2018-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1784213, encodeId=93a21e84213da, content=<a href='/topic/show?id=f01159527d' target=_blank style='color:#2F92EE;'>#Differ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5952, encryptionId=f01159527d, topicName=Differ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d784426, createdName=isabellayj, createdTime=Sat Jan 26 04:21:00 CST 2019, time=2019-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=337735, encodeId=65ce33e7358b, content=阅, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/fhZdOu27e88Voqh19n8eF8cLplo8L4nicKtH0WnE3KFELXns5XDu8rsiceK2HHDZc2SEStia5VV3Pia2QLMVqlWbHw/0, createdBy=6e012139475, createdName=神功盖世, createdTime=Fri Aug 10 18:13:10 CST 2018, time=2018-08-10, status=1, ipAttribution=)]
    2019-01-26 isabellayj
  5. [GetPortalCommentsPageByObjectIdResponse(id=1918235, encodeId=f6a31918235fa, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Mon Oct 15 10:21:00 CST 2018, time=2018-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1767499, encodeId=9cbd1e67499b5, content=<a href='/topic/show?id=64f5343e2f' target=_blank style='color:#2F92EE;'>#Biol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3437, encryptionId=64f5343e2f, topicName=Biol)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=446937890434, createdName=12498ebem31暂无昵称, createdTime=Sun Nov 25 18:21:00 CST 2018, time=2018-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1934423, encodeId=416a193442350, content=<a href='/topic/show?id=333851e5032' target=_blank style='color:#2F92EE;'>#心血管代谢#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51750, encryptionId=333851e5032, topicName=心血管代谢)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2bcd469, createdName=fengting3, createdTime=Wed Nov 28 23:21:00 CST 2018, time=2018-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1784213, encodeId=93a21e84213da, content=<a href='/topic/show?id=f01159527d' target=_blank style='color:#2F92EE;'>#Differ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5952, encryptionId=f01159527d, topicName=Differ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d784426, createdName=isabellayj, createdTime=Sat Jan 26 04:21:00 CST 2019, time=2019-01-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=337735, encodeId=65ce33e7358b, content=阅, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/fhZdOu27e88Voqh19n8eF8cLplo8L4nicKtH0WnE3KFELXns5XDu8rsiceK2HHDZc2SEStia5VV3Pia2QLMVqlWbHw/0, createdBy=6e012139475, createdName=神功盖世, createdTime=Fri Aug 10 18:13:10 CST 2018, time=2018-08-10, status=1, ipAttribution=)]
    2018-08-10 神功盖世

    0

相关资讯

JACC:冠脉微血管功能不良可作为肥胖患者的心血管风险分层因子

除了体重指数(BMI)外,尚需要其他的因素来鉴别肥胖患者的心血管风险。本研究的目的旨在评估肥胖、冠脉微血管功能不良(CMD)和不良反应事件的相关性。本研究对827名心脏灌注正电子发射断层显像显示正常灌注的肥胖患者进行平均5.6年时间的随访,观察事件主要包括死亡、心梗或心衰住院。分析结果显示,BMI与冠脉血流储备(CFR)呈倒J型曲线相关,即在肥胖患者中,CFR随着BMI的升高而降低(p <

J Infect Dis:肥胖,不仅影响流感的严重程度,它还会直接影响流感的传播

肥胖和超重的人数越来越多,根据2016年发表在《Lancet》的一项研究,全球成人肥胖者人数已超过体重过轻者,而中国的肥胖人数居全球首位。肥胖问题已成了全球性公共卫生危机。

BMJ:低BMI导致的营养不良及贫血风险远低于高BMI导致的超重及肥胖风险

研究认为,低体重指数与贫血和严重贫血的相关性较高体重指数与超重和肥胖的相关性相比要弱得多

JAHA:肥胖与外周动脉疾病和严重肢体缺血相关的住院事件相关

由此可见,在一般人群中,调整潜在的混杂因素后,BMI与PAD住院之间呈正相关,特别是其最严重的CLI类型。除控制其它心血管危险因素外,维持最佳体重可能会在降低伴有CLI的PAD风险方面发挥作用。

JAMA:多方位行为干预未能改善医疗条件不足的学龄前儿童肥胖

肥胖的发病始于儿童期,在少数族裔中发病率最高。大量研究提示干预儿童的健康行为,如饮食,睡眠等,可治疗儿童期肥胖,但疗效甚微,且只能在短期内降低儿童的体重指数(BMI),其疗效的可持续性尚未知。

PNAS:为什么肥胖容易引发疾病?

肥胖是流行于全球的健康问题,是包括糖尿病、心血管疾病和癌症在内的若干慢性病的主要风险因素。近期,《PNAS》期刊发文揭示了“肥胖引发疾病”的原由,并从中设想出两种阻止的方法,用于防治肥胖相关疾病。